A blood-based biomarker test may be a reliable method for predicting or ruling out Alzheimer’s disease-related pathology and ...

Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.

New research has shown that diet could influence the risk of both depression and Alzheimer's disease (AD). Evidence suggests that depressive symptoms are both a risk factor for AD and a reaction to ...

The bacteria in your mouth and on your tongue may be linked to changes in brain function as you age, new research suggested.

Researchers have conducted one of the largest eye studies in the world to reveal new insights into retinal thickness, highlighting its potential in the early detection of diseases like type 2 diabetes ...

Alzheimer’s is a mind-body malaise that experts say can take up to 20 years to run its fearsome course—like having a sliver ...

Cassava Sciences (SAVA)’ trial for simufilam 50 mg or 100 mg for mild-to-moderate Alzheimer’s disease, named “REFOCUS-ALZ,” has been ...

As a winter storm is expected to hit parts of the U.S. on Wednesday, officials with the Alzheimer’s Foundation of America ...

LEXINGTON, Mass., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced it will ...

A new study has found that taking longer to reach the rapid eye movement (REM) stage of sleep is linked to a greater risk of developing Alzheimer's disease.

Blue Yonder Holding, Inc. (Blue Yonder), the world leader in digital supply chain transformation, today released its Q4 2024 and FY24 company highlights, as well as the industry trends that matter ...

IT, a leader in Circular Technology Services with over 4 million devices under management, has announced its strategic expansion into the North American market ...